Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
This study is currently recruiting participants.
Verified July 2013
by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Study NCT01217697 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on October 7, 2010. Last Updated on July 31, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Genital Neoplasms, Male
Genital Diseases, Male
Additional conditions recognized in this trial
More general conditions related to this trial
Neoplasms by Site
Interventions listed in this trial
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers